Agilent Technologies (NYSE: A) and Precipio (NASDAQ:PRPO) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
This table compares Agilent Technologies and Precipio’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Agilent Technologies has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Precipio has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.
Valuation and Earnings
This table compares Agilent Technologies and Precipio’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Agilent Technologies||$4.47 billion||4.64||$684.00 million||$2.36||27.25|
|Precipio||$1.72 million||5.19||-$20.69 million||N/A||N/A|
Agilent Technologies has higher revenue and earnings than Precipio.
Institutional & Insider Ownership
7.4% of Precipio shares are owned by institutional investors. 24.7% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a breakdown of current ratings for Agilent Technologies and Precipio, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Agilent Technologies currently has a consensus price target of $72.21, suggesting a potential upside of 12.27%. Given Agilent Technologies’ higher possible upside, equities research analysts plainly believe Agilent Technologies is more favorable than Precipio.
Agilent Technologies pays an annual dividend of $0.60 per share and has a dividend yield of 0.9%. Precipio does not pay a dividend. Agilent Technologies pays out 25.4% of its earnings in the form of a dividend. Agilent Technologies has raised its dividend for 2 consecutive years.
Agilent Technologies beats Precipio on 10 of the 14 factors compared between the two stocks.
Agilent Technologies Company Profile
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Precipio Company Profile
Precipio, Inc. provides platform to eradicate the problem of misdiagnosis within academic institutions. The company also delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.